FDMT
4D Molecular Therapeutics Inc
14.50$
-0.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.7% | 97.0% | 90.2% | 98.0% | 72.5% | 84.2% | 87.3% | 77.6% | 72.9% | |
| 87.3% | 94.6% | 85.3% | 96.0% | 43.3% | 20.0% | 73.3% | 26.6% | 10.6% | |
| 87.3% | 94.6% | 85.3% | 96.0% | 70.1% | 81.6% | 84.8% | 75.8% | 71.1% | |
| 1.2% | 1.2% | 1.7% | 0.5% | 0.0% | 0.3% | – | – | – | |
| 0.0% | – | – | – | -2.4% | -2.2% | – | – | – | |
| 9.9% | 2.5% | 8.7% | 1.8% | 8.2% | 8.5% | – | – | – | |
| 171.7% | 128.4% | 225.3% | 11.1% | 9.7% | 11.7% | 9.4% | 8.9% | 10.8% | |
| 21.6% | 8.3% | 22.2% | 5.8% | 4.6% | 6.0% | 5.6% | 5.2% | 7.8% | |
| 0.2% | 0.1% | – | – | 0.3% | 1.0% | 0.9% | 1.0% | 1.0% | |
| 1.7% | 1.0% | 3.0% | 0.6% | 1.3% | 1.3% | 1.0% | 0.8% | 2.0% | |
| -71.7% | -28.4% | -125.3% | 88.9% | 90.3% | 88.3% | 90.6% | 91.1% | 89.2% | |
| -74.9% | -31.0% | -135.7% | -47.1% | -58.6% | -120.1% | -122.2% | -102.8% | -126.4% | |
| 54.3% | 12.9% | 45.5% | 9.3% | 7.8% | 12.4% | 11.5% | 9.6% | 10.2% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.